{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:47:15Z","timestamp":1777445235471,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T00:00:00Z","timestamp":1552953600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2017M3A9G2077568"],"award-info":[{"award-number":["2017M3A9G2077568"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2016R1D1AB02010387"],"award-info":[{"award-number":["2016R1D1AB02010387"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00213-019-05219-x","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:24:04Z","timestamp":1555507444000},"page":"2201-2210","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The novel methoxetamine analogs N-ethylnorketamine hydrochloride (NENK), 2-MeO-N-ethylketamine hydrochloride (2-MeO-NEK), and 4-MeO-N-ethylketamine hydrochloride (4-MeO-NEK) elicit rapid antidepressant effects via activation of AMPA and 5-HT2 receptors"],"prefix":"10.1007","volume":"236","author":[{"given":"Leandro Val","family":"Sayson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrislean Jun","family":"Botanas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raly James Perez","family":"Custodio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvie","family":"Abiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Yeun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Won","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srijan","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong-Man","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Sup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jae Hoon","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,19]]},"reference":[{"issue":"4","key":"5219_CR1","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1503\/jpn.160175","volume":"42","author":"LR Aleksandrova","year":"2017","unstructured":"Aleksandrova LR, Phillips AG, Wang YT (2017) Antidepressant effects of ketamine and the roles of AMPA glutamate receptors and other mechanisms beyond NMDA receptor antagonism. J Psychiatry Neurosci 42(4):222\u2013229","journal-title":"J Psychiatry Neurosci"},{"key":"5219_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, Kavalali ET, Monteggia LM (2011) NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 475:91\u201395","journal-title":"Nature"},{"key":"5219_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.08.038","volume":"126","author":"CJ Botanas","year":"2017","unstructured":"Botanas CJ, Bryan de la Pe\u00f1a J, Custodio RJ, Joy dela Pe\u00f1a I, Kim M, Woo T, Kim HJ, Kim HI, Chang Cho M, Lee YS, Cheong JH (2017) Methoxetamine produces rapid and sustained antidepressant effects probably via glutamatergic and serotonergic mechanisms. Neuropharmacology 126:121\u2013127","journal-title":"Neuropharmacology"},{"key":"5219_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3389\/fphar.2013.00161","volume":"4","author":"CA Browne","year":"2013","unstructured":"Browne CA, Lucki I (2013) Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants. Front Pharmacol 4:161","journal-title":"Front Pharmacol"},{"key":"5219_CR5","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1021\/bi00703a019","volume":"13","author":"YC Cheng","year":"1974","unstructured":"Cheng YC, Prusoff WH (1974) Mouse ascites sarcoma 180 deoxythymidine kinase. General properties and inhibition studies. Biochemistry 13:1179\u20131185","journal-title":"Biochemistry"},{"key":"5219_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, Leucht S, Ruhe HG, Turner EH, Higgins JPT, Egger M, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Tajika A, Ioannidis JPA, Geddes JR (2018) Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet 391:1357\u20131366","journal-title":"Lancet"},{"key":"5219_CR7","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.mehy.2012.07.002","volume":"79","author":"M Coppola","year":"2012","unstructured":"Coppola M, Mondola R (2012) Methoxetamine: from drug of abuse to rapid-acting antidepressant. Med Hypotheses 79:504\u2013507","journal-title":"Med Hypotheses"},{"key":"5219_CR8","doi-asserted-by":"crossref","unstructured":"Custodio RJP, Botanas CJ, Yoon SS, Pena JB, Pena IJ, Kim M, Woo T, Seo JW, Jang CG, Kwon YH, Kim NY, Lee YS, Kim HJ, Cheong JH (2017) Evaluation of the abuse potential of novel amphetamine derivatives with modifications on the amine (NBNA) and phenyl (EDA, PMEA, 2-APN) sites. Biomol Ther 25:578\u2013585","DOI":"10.4062\/biomolther.2017.141"},{"key":"5219_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ejphar.2016.05.029","volume":"786","author":"KG Jardin du","year":"2016","unstructured":"du Jardin KG, M\u00fcller HK, Sanchez C, Wegener G, Elfving B (2016) A single dose of vortioxetine, but not ketamine or fluoxetine, increases plasticity-related gene expression in the rat frontal cortex. Eur J Pharmacol 786:29\u201335","journal-title":"Eur J Pharmacol"},{"key":"5219_CR10","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.tins.2011.11.004","volume":"35","author":"RS Duman","year":"2012","unstructured":"Duman RS, Voleti B (2012) Signaling pathways underlying the pathophysiology and treatment of depression: novel mechanisms for rapid-acting agents. Trends Neurosci 35:47\u201356","journal-title":"Trends Neurosci"},{"issue":"3","key":"5219_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nm.4050","volume":"22","author":"RS Duman","year":"2016","unstructured":"Duman RS, Aghajanian GK, Sanacora G, Krystal JH (2016) Synaptic plasticity and depression: new insights from stress and rapid-acting antidepressants. Nat Med 22(3):238\u2013249","journal-title":"Nat Med"},{"key":"5219_CR12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1017\/S1461145711001702","volume":"15","author":"JM Dwyer","year":"2012","unstructured":"Dwyer JM, Lepack AE, Duman RS (2012) mTOR activation is required for the antidepressant effects of mGluR2\/3 blockade. Int J Neuropsychopharmacol 15:429\u2013434","journal-title":"Int J Neuropsychopharmacol"},{"key":"5219_CR13","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41598-017-01035-5","volume":"7","author":"J Fan","year":"2017","unstructured":"Fan J, Li B, Ge T, Zhang Z, Lv J, Zhao J, Wang P, Liu W, Wang X, Mlyniec K, Cui R (2017) Berberine produces antidepressant-like effects in ovariectomized mice. Sci Rep 7:1310","journal-title":"Sci Rep"},{"key":"5219_CR14","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1016\/j.pnpbp.2010.06.013","volume":"35","author":"K Hashimoto","year":"2011","unstructured":"Hashimoto K (2011) The role of glutamate on the action of antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatry 35:1558\u20131568","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5219_CR15","first-page":"3","volume":"9","author":"PA Hays","year":"2012","unstructured":"Hays PA, Casale JF, Berrier AL (2012) The characterization of 2-(3-methoxyphenyl)-2-(ethylamino) cyclohexanone (methoxetamine). Microgram Journal 9:3\u201317","journal-title":"Microgram Journal"},{"issue":"20","key":"5219_CR16","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.1093\/hmg\/ddq311","volume":"19","author":"SS H\u00e9bert","year":"2010","unstructured":"H\u00e9bert SS, Papadopoulou AS, Smith P, Galas MC, Planel E, Silahtaroglu AN, Sergeant N, Bu\u00e9e L, de Strooper B (2010) Genetic ablation of Dicer in adult forebrain neurons results in abnormal tau hyperphosphorylation and neurodegeneration. Hum Mol Genet 19(20):3959\u20133969","journal-title":"Hum Mol Genet"},{"key":"5219_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1037\/a0038550","volume":"23","author":"TM Hillhouse","year":"2015","unstructured":"Hillhouse TM, Porter JH (2015) A brief history of the development of antidepressant drugs: from monoamines to glutamate. Exp Clin Psychopharmacol 23:1\u201321","journal-title":"Exp Clin Psychopharmacol"},{"issue":"7","key":"5219_CR18","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.pnpbp.2011.05.010","volume":"35","author":"CS Jernigan","year":"2011","unstructured":"Jernigan CS, Goswami DB, Austin MC, Iyo AH, Chandran A, Stockmeier CA, Karolewicz B (2011) The mTOR signaling pathway in the prefrontal cortex is compromised in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 35(7):1774\u20131779","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"5219_CR19","doi-asserted-by":"publisher","unstructured":"Kim M, Custodio RJ, Botanas CJ, de la Pe\u00f1a JB, Sayson LV, Abiero A, Ryoo ZY, Cheong JH, Kim HJ (2018) The circadian gene, Per2, influences methamphetamine sensitization and reward through the dopaminergic system in the striatum of mice. Addict Biol. \n                    https:\/\/doi.org\/10.1111\/adb.12663","DOI":"10.1111\/adb.12663"},{"key":"5219_CR20","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.neuropharm.2011.08.034","volume":"61","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S (2011a) Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists. Neuropharmacology 61:1419\u20131423","journal-title":"Neuropharmacology"},{"issue":"1","key":"5219_CR21","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbr.2011.05.035","volume":"224","author":"H Koike","year":"2011","unstructured":"Koike H, Iijima M, Chaki S (2011b) Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression. Behav Brain Res 224(1):107\u2013111","journal-title":"Behav Brain Res"},{"key":"5219_CR22","doi-asserted-by":"publisher","first-page":"9009","DOI":"10.1038\/srep09009","volume":"5","author":"E Kong","year":"2015","unstructured":"Kong E, Sucic S, Monje FJ, Reisinger SN, Savalli G, Diao W, Khan D, Ronovsky M, Cabatic M, Koban F, Freissmuth M, Pollak DD (2015) STAT3 controls IL6-dependent regulation of serotonin transporter function and depression-like behavior. Sci Rep 5:9009","journal-title":"Sci Rep"},{"issue":"3","key":"5219_CR23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/dneu.22232","volume":"75","author":"M Lecointre","year":"2015","unstructured":"Lecointre M, V\u00e9zier C, B\u00e9nard M, Ramdani Y, Dupr\u00e9 N, Brasse-Lagnel C, Henry VJ, Roy V, Marret S, Gonzalez BJ, J\u00e9gou S, Leroux-Nicollet I (2015) Age-dependent alterations of the NMDA receptor developmental profile and adult behavior in postnatally ketamine-treated mice. Dev Neurobiol 75(3):315\u2013333","journal-title":"Dev Neurobiol"},{"issue":"5994","key":"5219_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1190287","volume":"329","author":"N Li","year":"2010","unstructured":"Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M, Li XY, Aghajanian G, Duman RS (2010) mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science 329(5994):959\u2013964","journal-title":"Science"},{"key":"5219_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/6871089","volume":"2017","author":"W Liu","year":"2017","unstructured":"Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, Cui R (2017) The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast 2017:1\u201311. \n                    https:\/\/doi.org\/10.1155\/2017\/6871089","journal-title":"Neural Plast"},{"issue":"4","key":"5219_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.biopsych.2007.05.028","volume":"63","author":"S Maeng","year":"2008","unstructured":"Maeng S, Zarate CA Jr, du J, Schloesser RJ, McCammon J, Chen G, Manji HK (2008) Cellular mechanisms underlying the antidepressant effects of ketamine: role of \u03b1-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors. Biol Psychiatry 63(4):349\u2013352","journal-title":"Biol Psychiatry"},{"key":"5219_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1176\/appi.ajp.160.1.90","volume":"160","author":"JH Meyer","year":"2003","unstructured":"Meyer JH, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN, Wilson AA, Blak T, Eynan-Harvey R, Goulding VS, Houle S, Links P (2003) Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatr 160:90\u201399","journal-title":"Am J Psychiatr"},{"key":"5219_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0006-8993(91)91705-6","volume":"566","author":"N Mitrovic","year":"1991","unstructured":"Mitrovic N, Caboche J, Carr\u00e9 JB, Besson MJ, Maurin Y (1991) The quaking mouse: an epileptic mutant with alterations affecting the modulatory mechanisms of the NMDA receptor complex. Brain Res 566:248\u2013254","journal-title":"Brain Res"},{"key":"5219_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.conb.2014.12.004","volume":"30","author":"LM Monteggia","year":"2015","unstructured":"Monteggia LM, Zarate C Jr (2015) Antidepressant actions of ketamine: from molecular mechanisms to clinical practice. Curr Opin Neurobiol 30:139\u2013143","journal-title":"Curr Opin Neurobiol"},{"key":"5219_CR30","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/clpt.2011.244","volume":"91","author":"JW Murrough","year":"2012","unstructured":"Murrough JW (2012) Ketamine as a novel antidepressant: from synapse to behavior. Clin Pharmacol Ther 91:303\u2013309","journal-title":"Clin Pharmacol Ther"},{"issue":"10","key":"5219_CR31","doi-asserted-by":"publisher","first-page":"6818","DOI":"10.1007\/s12035-015-9580-9","volume":"53","author":"FL Pazini","year":"2016","unstructured":"Pazini FL, Cunha MP, Rosa JM, Colla ARS, Lieberknecht V, Oliveira \u00c1, Rodrigues ALS (2016) Creatine, similar to ketamine, counteracts depressive-like behavior induced by corticosterone via PI3K\/Akt\/mTOR pathway. Mol Neurobiol 53(10):6818\u20136834","journal-title":"Mol Neurobiol"},{"issue":"9","key":"5219_CR32","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1517\/13543784.2014.918951","volume":"23","author":"B Pochwat","year":"2014","unstructured":"Pochwat B, Pa\u0142ucha-Poniewiera A, Szewczyk B, Pilc A, Nowak G (2014) NMDA antagonists under investigation for the treatment of major depressive disorder. Expert Opin Investig Drugs 23(9):1181\u20131192","journal-title":"Expert Opin Investig Drugs"},{"key":"5219_CR33","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","volume":"163","author":"AJ Rush","year":"2006","unstructured":"Rush AJ et al (2006) Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatr 163:1905\u20131917","journal-title":"Am J Psychiatr"},{"key":"5219_CR34","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1017\/neu.2015.14","volume":"27","author":"P Skolnick","year":"2015","unstructured":"Skolnick P, Kos T, Czekaj J, Popik P (2015) Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatr 27:228\u2013234","journal-title":"Acta Neuropsychiatr"},{"issue":"5","key":"5219_CR35","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2144\/000112776","volume":"44","author":"HD VanGuilder","year":"2008","unstructured":"VanGuilder HD, Vrana KE, Freeman WM (2008) Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44(5):619\u2013626","journal-title":"Biotechniques"},{"key":"5219_CR36","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bbr.2010.10.009","volume":"217","author":"I Vollenweider","year":"2011","unstructured":"Vollenweider I, Smith KS, Keist R, Rudolph U (2011) Antidepressant-like properties of \u03b12-containing GABAA receptors. Behav Brain Res 217:77\u201380","journal-title":"Behav Brain Res"},{"key":"5219_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/03009734.2012.724118","volume":"118","author":"C Yang","year":"2013","unstructured":"Yang C, Hu Y-M, Zhou Z-Q, Zhang G-F, Yang J-J (2013) Acute administration of ketamine in rats increases hippocampal BDNF and mTOR levels during forced swimming test. Ups J Med Sci 118:3\u20138","journal-title":"Ups J Med Sci"},{"issue":"1","key":"5219_CR38","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.biopsych.2017.10.026","volume":"83","author":"P Zanos","year":"2018","unstructured":"Zanos P, Gould TD (2018) Intracellular signaling pathways involved in (S)- and (R)-ketamine antidepressant actions. Biol Psychiatry 83(1):2\u20134","journal-title":"Biol Psychiatry"},{"key":"5219_CR39","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, Alkondon M, Yuan P, Pribut HJ, Singh NS, Dossou KSS, Fang Y, Huang XP, Mayo CL, Wainer IW, Albuquerque EX, Thompson SM, Thomas CJ, Zarate Jr CA, Gould TD (2016) NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 533:481\u2013486","journal-title":"Nature"},{"key":"5219_CR40","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/archpsyc.63.8.856","volume":"63","author":"CA Zarate","year":"2006","unstructured":"Zarate CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63:856\u2013864","journal-title":"Arch Gen Psychiatry"},{"key":"5219_CR41","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejphar.2011.12.041","volume":"679","author":"ALB Zeni","year":"2012","unstructured":"Zeni ALB, Zomkowski ADE, Maraschin M, Rodrigues ALS, Tasca CI (2012) Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system. Eur J Pharmacol 679:68\u201374","journal-title":"Eur J Pharmacol"},{"key":"5219_CR42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brainres.2010.09.095","volume":"1366","author":"Y Zhang","year":"2010","unstructured":"Zhang Y, Gu F, Chen J, Dong W (2010) Chronic antidepressant administration alleviates frontal and hippocampal BDNF deficits in CUMS rat. Brain Res 1366:141\u2013148","journal-title":"Brain Res"},{"key":"5219_CR43","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.eurpsy.2013.10.005","volume":"29","author":"W Zhou","year":"2014","unstructured":"Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ (2014) Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex. Eur Psychiatry 29:419\u2013423","journal-title":"Eur Psychiatry"},{"key":"5219_CR44","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","volume":"1023","author":"ADE Zomkowski","year":"2004","unstructured":"Zomkowski ADE et al (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023:253\u2013263","journal-title":"Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-019-05219-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-019-05219-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:09:28Z","timestamp":1584490168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-019-05219-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,19]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["5219"],"URL":"https:\/\/doi.org\/10.1007\/s00213-019-05219-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,19]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}